Prescription drug · ANDA
prazosin hydrochloride NDC 72205-277
Prazosin hydrochloride 5 mg/1 · Capsule · Oral · Novadoz Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72205-277-91 | 72205027791 | 100 CAPSULE in 1 BOTTLE (72205-277-91)Marketed from Apr 16, 2025 | |
| 72205-277-95 | 72205027795 | 250 CAPSULE in 1 BOTTLE (72205-277-95)Marketed from Apr 16, 2025 | |
| 72205-277-99 | 72205027799 | 1000 CAPSULE in 1 BOTTLE (72205-277-99)Marketed from Apr 16, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- prazosin hydrochloride
- Generic name (nonproprietary)
- prazosin hydrochloride
- Active ingredients
- Prazosin hydrochloride — 5 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Novadoz Pharmaceuticals LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 216727
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 72205-277_486d4f26-60ae-4e6c-aa36-0b298a7f9aedSPL ID 486d4f26-60ae-4e6c-aa36-0b298a7f9aedSPL set ID 486d4f26-60ae-4e6c-aa36-0b298a7f9aedRxCUI 198141, 312593, 312594UNII X0Z7454B90UPC 0372205277991, 0372205275997, 0372205276956, 0372205275911, 0372205275904, 0372205277953, 0372205276994, 0372205275959, 0372205276918, 0372205277915
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472205027791followed by a unit qualifier and the quantityPackage 72205-0277-91. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Prazosin hydrochloride capsules are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve b…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 216727
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| prazosin hydrochloride | Prazosin hydrochloride 1 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-4712 |
| prazosin hydrochloride | Prazosin hydrochloride 2 mg/1 | CapsuleOral | Novadoz Pharmaceuticals LLC | 72205-276 |
| prazosin hydrochloride | Prazosin hydrochloride 1 mg/1 | CapsuleOral | Novadoz Pharmaceuticals LLC | 72205-275 |